It also indicated that the mRNA expression levels of FBXO20 and FBXO45 were closely related to the tumor stage of PDAC patients (Supplementary Figure S5B), which meant that patients who were in more advanced tumor staging tended to express higher transcripts of FBXO20, FBXO32, and FBXO45. Here, FBXO32 is linked to neoplasm.